Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-acyl homoserine lactone (AHL) synthase is a bacterial enzyme, primarily found in Gram-negative Proteobacteria, that catalyzes the synthesis of AHL signaling molecules [11, 14]. These molecules serve as the primary autoinducers for quorum sensing, a sophisticated communication process that allows bacteria to coordinate gene expression in response to population density [1, 11]. The enzyme utilizes S-adenosyl-L-methionine (SAM) and acylated acyl carrier proteins (acyl-ACP) as substrates to produce AHLs, which then diffuse out of the cell to signal neighboring bacteria [9, 14]. At high concentrations, these signals bind to cognate LuxR-type receptors, triggering the expression of genes involved in biofilm formation, motility, and the production of various virulence factors [1, 17]. Because AHL synthase is essential for the pathogenicity of major human pathogens like Pseudomonas aeruginosa, it has become a prominent target for 'anti-virulence' or 'quorum-quenching' therapies [3, 17]. Inhibiting this enzyme aims to disrupt bacterial communication and 'disarm' the pathogen without imposing the strong selective pressure for resistance associated with traditional bactericidal antibiotics [1, 17]. Current research focuses on developing small-molecule inhibitors, including SAM analogs and substrate mimics, to treat chronic and multidrug-resistant infections [7, 9].
Inhibition of the synthesis of N-acyl homoserine lactone (AHL) signaling molecules by blocking the enzyme's active site or competing with its substrates, S-adenosyl-L-methionine (SAM) and acylated acyl carrier protein (acyl-ACP).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-acyl homoserine lactone synthase (AHL synthase) (AHL synthase).